Predictive value of long-term changes of growth differentiation factor-15 over a 27-year-period for heart failure and death due to coronary heart disease

Evaluation of Temporal Changes in Cardiovascular Biomarker Concentrations Improves Risk Prediction in an Elderly Population from the Community

(2016) K. M. Eggers et al.   CLINICAL CHEMISTRY

Association of Repeatedly Measured High-Sensitivity–Assayed Troponin I with Cardiovascular Disease Events in a General Population from the MORGAM/BiomarCaRE Study

(2016) Maria F. Hughes et al.   CLINICAL CHEMISTRY

2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure

(2016) Piotr Ponikowski et al.   EUROPEAN JOURNAL OF HEART FAILURE

Joint modelling of repeated measurement and time-to-event data: an introductory tutorial

(2015) Özgür Asar et al.   INTERNATIONAL JOURNAL OF EPIDEMIOLOGY

BiomarCaRE: rationale and design of the European BiomarCaRE project including 300,000 participants from 13 European countries

(2014) Tanja Zeller et al.   EUROPEAN JOURNAL OF EPIDEMIOLOGY

Cystatin C identifies cardiovascular risk better than creatinine-based estimates of glomerular filtration in middle-aged individuals without a history of cardiovascular disease

(2013) P. Svensson-Färbom et al.   JOURNAL OF INTERNAL MEDICINE

GDF-15 for Prognostication of Cardiovascular and Cancer Morbidity and Mortality in Men

(2013) Lars Wallentin et al.   PLoS One

Bioactivity and Prognostic Significance of Growth Differentiation Factor GDF15 Secreted by Bone Marrow Mesenchymal Stem Cells in Multiple Myeloma

(2012) J. Corre et al.   CANCER RESEARCH

Prognostic Utility of Novel Biomarkers of Cardiovascular Stress

(2012) Thomas J. Wang et al.   CIRCULATION

Growth-Differentiation Factor-15 Is a Robust, Independent Predictor of 11-Year Mortality Risk in Community-Dwelling Older Adults

(2011) Lori B. Daniels et al.   CIRCULATION

Association of Growth Differentiation Factor-15 with Coronary Atherosclerosis and Mortality in a Young, Multiethnic Population: Observations from the Dallas Heart Study

(2011) A. Rohatgi et al.   CLINICAL CHEMISTRY

Macrophage inhibitory cytokine-1 (MIC-1/GDF15): a new marker of all-cause mortality

(2010) Fredrik E. Wiklund et al.   AGING CELL

Serial Measurement of Growth-Differentiation Factor-15 in Heart Failure

(2010) Inder S. Anand et al.   CIRCULATION

Contribution of 30 Biomarkers to 10-Year Cardiovascular Risk Estimation in 2 Population Cohorts

(2010) Stefan Blankenberg et al.   CIRCULATION

The cohorts at the Research Centre for Prevention and Health, formerly 'The Glostrup Population Studies'

(2010) M. Osler et al.   INTERNATIONAL JOURNAL OF EPIDEMIOLOGY

Epidemiology and risk profile of heart failure

(2010) Anh L. Bui et al.   Nature Reviews Cardiology

Growth-Differentiation Factor-15 for Risk Stratification in Patients With Stable and Unstable Coronary Heart Disease

(2009) Tibor Kempf et al.   Circulation-Cardiovascular Genetics

Clinical Correlates and Heritability of Cystatin C (from the Framingham Offspring Study)

(2008) Nisha I. Parikh et al.   AMERICAN JOURNAL OF CARDIOLOGY

Use of Multiple Biomarkers to Improve the Prediction of Death from Cardiovascular Causes

(2008) Björn Zethelius et al.   NEW ENGLAND JOURNAL OF MEDICINE

Gene Expression Pattern in Biomechanically Stretched Cardiomyocytes

(2007) Derk Frank et al.   HYPERTENSION